Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 25, 2026
Why Is GraniteShares 2x Long DELL Daily ETF (DLLL) Up +12.84% Today?

Why Is GraniteShares 2x Long DELL Daily ETF (DLLL) Up +12.84% Today?

Key Takeaways

  • DLLL surged 12.84% in today's session, adding $4.17 to reach $36.65 versus a prior close of $32.48.
  • The move was powered by a sharp rally in Dell Technologies (DELL), the single underlying security this leveraged fund tracks at 2x daily exposure.
  • A bullish Morgan Stanley note raising the probability of a $756 bull-case scenario on Dell was the primary catalyst.
  • The fund's leverage amplified Dell's rebound after the stock pulled back earlier in the week.
  • Because DLLL resets its exposure daily, its percentage gain was roughly double Dell's intraday advance.
  • Investors are now watching whether Dell's AI infrastructure momentum can sustain the move into the next session.

Opening Summary

The GraniteShares 2x Long DELL Daily ETF (DLLL) is a leveraged single-stock exchange-traded fund designed to deliver approximately two times the daily return of Dell Technologies Inc. (DELL). In today's session, the fund jumped 12.84%, rising from a prior close of $32.48 to $36.65 as of the latest intraday quote. The direction of the move is unambiguously higher, and it reflects a double-digit percentage gain in the fund's underlying exposure as Dell shares rallied on renewed confidence in its artificial-intelligence server business.

What Drove the ETF Move Today

A Bullish Analyst Note on Dell

The most direct catalyst behind DLLL's surge was a research note from Morgan Stanley, which raised the probability attached to its $756 bull-case scenario for Dell following a private meeting with Dell Chief Operating Officer Jeff Clarke. While the firm kept its Neutral rating and base-case price target unchanged, the higher likelihood assigned to the more optimistic scenario was enough to re-ignite buyer interest in the stock, and by extension, in the leveraged fund that tracks it.

AI Infrastructure Momentum

Clarke's message to analysts centered on the idea that AI spending represents a structural expansion of Dell's addressable market rather than a simple hardware replacement cycle. He projected that AI agents could drive inference-token usage roughly 87 times higher by 2030, implying meaningful additional demand for computing capacity. That outlook reinforced the broader thesis that Dell remains a primary beneficiary of the AI infrastructure buildout, supporting a sector-driven move in both the stock and the leveraged ETF.

A Rebound From Earlier-Week Weakness

DLLL's gain also reflects a technical rebound. Dell shares had pulled back earlier in the week, pressured in part by reports of a contractual dispute and potential timeline slippage at a major data-center project and by insider stock sales. With Dell trading well below its recent 52-week high, today's bullish commentary gave buyers a fresh entry point, and the leveraged fund's structure magnified the resulting upside.

Which Holdings Contributed Most

DLLL does not hold a diversified basket of individual stocks. As a single-stock leveraged ETF, its performance is driven almost entirely by one underlying security: Dell Technologies (DELL), which the fund tracks through swap agreements and other derivatives rather than direct share ownership. Consequently, virtually all of today's move can be attributed to Dell's rally. Dell's strong fundamental backdrop — including a record quarterly revenue figure, a roughly $95 billion AI server backlog, and rising AI-optimized server orders — provided the foundation for the stock's advance that DLLL amplified through its 2x daily leverage.

Market Context and Trading Activity

The move in DLLL was primarily a company-specific event rather than a broad-market phenomenon. The broader market offered little directional help, with major U.S. indexes trading near flat or mixed during the session, underscoring that Dell — and its leveraged proxy — moved on idiosyncratic catalysts tied to the AI infrastructure theme. Trading activity in the fund reflected the surge in the underlying stock, and the sharpness of the intraday gain pushed the fund well above its most recent closing level, breaking decisively to the upside after several days of consolidation and decline.

What Comes Next for DLLL

Looking ahead, investors will be monitoring several factors that could shape DLLL's near-term path. The most important is whether Dell's AI server momentum continues, including the pace of AI GPU server orders, the trajectory of its sizable backlog, and any updates on guidance or customer demand. Broader AI infrastructure sentiment, cloud-provider capital spending, and interest-rate expectations will also matter, as they influence risk appetite for high-momentum technology names. Additionally, traders should be aware that as a 2x daily leveraged fund, DLLL is designed for short-term holding periods and can diverge significantly from Dell's returns over longer timeframes due to daily resetting and compounding effects. Volatility in Dell itself — including potential profit-taking after this week's rebound — remains a key risk to monitor.

Trending AI Robots

For traders seeking a more systematic approach, Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore different approaches. Visit Trending AI Robots to discover which strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: DLLL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for DLLL turns positive, indicating new upward trend

DLLL saw its Momentum Indicator move above the 0 level on September 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator turned positive. In 22 of the 22 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

DLLL moved above its 50-day moving average on September 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for DLLL crossed bullishly above the 50-day moving average on September 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +16.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where DLLL advanced for three days, in 98 of 103 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 126 of 133 cases where DLLL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 20 of 21 cases where DLLL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for DLLL turned negative on September 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 17 similar instances when the indicator turned negative. In 15 of the 17 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

DLLL broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks daily investment results, before fees and expenses, of 2 times (200%) the daily percentage change of the common stock of Dell Technologies Inc. The fund is an actively managed exchange traded fund that attempts to replicate 2 times (200%) the daily percentage change the underlying stock by entering into financial instruments such as swaps and options on the underlying stock as well as directly purchasing the underlying stock. The fund is non-diversified.
View a ticker or compare two or three
DLLL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
GraniteShares ETF Trust30 Vesey Street, 9th FloorNew York
Phone
N/A
Web
N/A
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Why Is GraniteShares 2x Long DELL Daily ETF (DLLL) Up +12.84% Today?